Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
30
OCX Quote, Financials, Valuation and Earnings
Last price:
$2.18
Seasonality move
:
23.49%
Day range:
$2.18 - $2.43
52-week range:
$1.97 - $3.57
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
34.81x
P/B ratio:
3.97x
Volume:
48.3K
Avg. volume:
111.6K
1-year change:
-34.12%
Market cap:
$38.6M
Revenue:
$1.5M
EPS (TTM):
-$4.54
OncoCyte SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
OCX
OncoCyte
|
04/28/2020 | 10-K | 10-K filing on 04/28/2020 | View Form |
|
OCX
OncoCyte
|
03/26/2020 | 10-K | 10-K filing on 03/26/2020 | View Form |
|
OCX
OncoCyte
|
11/14/2019 | 10-Q | 10-Q filing on 11/14/2019 | View Form |
|
OCX
OncoCyte
|
08/14/2019 | 10-Q | 10-Q filing on 08/14/2019 | View Form |
|
OCX
OncoCyte
|
05/14/2019 | 10-Q | 10-Q filing on 05/14/2019 | View Form |
|
OCX
OncoCyte
|
04/30/2019 | 10-K | 10-K filing on 04/30/2019 | View Form |
|
OCX
OncoCyte
|
04/01/2019 | 10-K | 10-K filing on 04/01/2019 | View Form |
|
OCX
OncoCyte
|
11/13/2018 | 10-Q | 10-Q filing on 11/13/2018 | View Form |
|
OCX
OncoCyte
|
08/14/2018 | 10-Q | 10-Q filing on 08/14/2018 | View Form |
|
OCX
OncoCyte
|
05/15/2018 | 10-Q | 10-Q filing on 05/15/2018 | View Form |
|
OCX
OncoCyte
|
04/30/2018 | 10-K | 10-K filing on 04/30/2018 | View Form |
|
OCX
OncoCyte
|
04/02/2018 | 10-K | 10-K filing on 04/02/2018 | View Form |
|
OCX
OncoCyte
|
11/14/2017 | 10-Q | 10-Q filing on 11/14/2017 | View Form |
|
OCX
OncoCyte
|
08/14/2017 | 10-Q | 10-Q filing on 08/14/2017 | View Form |
|
OCX
OncoCyte
|
04/28/2017 | 10-Q | 10-Q filing on 04/28/2017 | View Form |
|
OCX
OncoCyte
|
02/27/2017 | 10-K | 10-K filing on 02/27/2017 | View Form |
|
OCX
OncoCyte
|
11/10/2016 | 10-Q | 10-Q filing on 11/10/2016 | View Form |
|
OCX
OncoCyte
|
08/11/2016 | 10-Q | 10-Q filing on 08/11/2016 | View Form |
|
OCX
OncoCyte
|
05/24/2016 | 10-K | 10-K filing on 05/24/2016 | View Form |
|
OCX
OncoCyte
|
05/16/2016 | 10-Q | 10-Q filing on 05/16/2016 | View Form |
|
OCX
OncoCyte
|
03/30/2016 | 10-K | 10-K filing on 03/30/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 8
Inari Medical [NARI] is up 22.25% over the past day.
Sell
38
UNF alert for Jan 8
UniFirst [UNF] is up 20.59% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 19.13% over the past day.
